PDT Partners’s Travere Therapeutics TVTX Stock Holding History

PDT Partners’s Portfolio TVTX Stock Details TVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$5.17M	Buy	349,577 +40,043	+13%	+$593K	0.29%	100
2025 Q1	$5.55M	Buy	309,534 +62,425	+25%	+$1.12M	0.39%	55
2024 Q4	$4.3M	Sell	247,109 -17,164	-6%	-$299K	0.38%	64
2024 Q3	$3.7M	Buy	264,273 +25,490	+11%	+$357K	0.33%	70
2024 Q2	$1.96M	Buy	238,783 +43,242	+22%	+$355K	0.19%	205
2024 Q1	$1.51M	Buy	195,541 +134,020	+218%	+$1.03M	0.14%	249
2023 Q4	$553K	Buy	+61,521	New	+$553K	0.06%	393
2023 Q3	–	Sell	-23,845	Closed	-$366K	–	685
2023 Q2	$366K	Sell	23,845 -23,850	-50%	-$366K	0.05%	426
2023 Q1	$1.07M	Buy	+47,695	New	+$1.07M	0.15%	242
2022 Q3	–	Sell	-96,905	Closed	-$2.35M	–	1092
2022 Q2	$2.35M	Sell	96,905 -12,578	-11%	-$305K	0.21%	137
2022 Q1	$2.82M	Buy	109,483 +96,274	+729%	+$2.48M	0.24%	112
2021 Q4	$410K	Buy	+13,209	New	+$410K	0.03%	584
2021 Q1	–	Sell	-28,563	Closed	-$778K	–	886
2020 Q4	$778K	Sell	28,563 -23,472	-45%	-$639K	0.05%	375
2020 Q3	$961K	Buy	52,035 +35	+0.1%	+$646	0.06%	315
2020 Q2	$1.06M	Buy	52,000 +12,900	+33%	+$263K	0.07%	275
2020 Q1	$570K	Buy	+39,100	New	+$570K	0.05%	342
2019 Q3	–	Sell	-27,064	Closed	-$544K	–	484
2019 Q2	$544K	Sell	27,064 -36,969	-58%	-$743K	0.03%	302
2019 Q1	$1.45M	Sell	64,033 -4,142	-6%	-$93.7K	0.08%	228
2018 Q4	$1.54M	Buy	68,175 +2,123	+3%	+$48.1K	0.09%	232
2018 Q3	$1.9M	Buy	66,052 +5,593	+9%	+$161K	0.08%	244
2018 Q2	$1.65M	Sell	60,459 -36,427	-38%	-$993K	0.06%	282
2018 Q1	$2.17M	Sell	96,886 -182	-0.2%	-$4.07K	0.07%	264
2017 Q4	$2.05M	Sell	97,068 -33,391	-26%	-$703K	0.06%	299
2017 Q3	$3.25M	Sell	130,459 -20,700	-14%	-$515K	0.11%	223
2017 Q2	$2.93M	Buy	151,159 +115,503	+324%	+$2.24M	0.12%	216
2017 Q1	$658K	Buy	+35,656	New	+$658K	0.03%	356
2015 Q3	–	Sell	-30,240	Closed	-$1M	–	1576
2015 Q2	$1M	Sell	30,240 -9,519	-24%	-$315K	0.03%	746
2015 Q1	$953K	Buy	+39,759	New	+$953K	0.02%	805